Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

Representative before the EPO

Technology company logo thumb
no operation time available
1 office
Technology Company

We have observed 1 EP application Rachel Maria Lowry has served for within the last five+ years. (We consider all applications which have an EP A1 publication dated after January 19, 2013). Please note, that we only count EP applications, in which the name of the patent attorney is explicitly mentioned as representative. These EP applications are:

EP14171857

Phenoxypyridinylamide derivatives and their use in the treatment of PDE4 mediated disease states

IPC classification:
A61K 31/455, A61P 9/00, A61P 25/00, A61P 35/00, A61P 37/00, C07D 213/82, C07D 401/12, C07D 401/14, C07D 413/12, C07D 413/14, C07D 417/12, C07D 417/14, C07D 471/04, C07D 487/04, C07D 498/04
Applicant:
AstraZeneca AB
Applicant:
Galderma S.A.
Agent:
AstraZeneca PLC
Agent:
Rachel Maria Lowry, AstraZeneca UK Limited
Status:
PATENT GRANTED

Please Sign in to use this feature